BILL vs BMI

BILL Holdings has a weak financial health profile with a Piotroski F-Score of 4/9, indicating borderline stability, and lacks an Altman Z-Score for definitive distress risk assessment. Despite solid revenue growth of 10.4% and strong gross margins of 83.85%, profitability remains fragile with negative operating and return metrics. The stock trades below analyst target of $61.59, suggesting upside potential, but weak recent price performance and insider selling raise caution. While valuation multiples are reasonable relative to sector averages, inconsistent earnings and lack of cash flow data limit confidence in a strong recovery.

The Advanced Deterministic Scorecard shows a weak Piotroski F-Score of 4/9, indicating marginal financial health, and the absence of an Altman Z-Score prevents a full solvency risk assessment. Despite solid profitability metrics like 21.45% ROE and 19.57% operating margin, elevated valuation (P/E of 36.77 vs. sector average of 84.87) and bearish technical trend (0/100) offset strength in fundamentals. Revenue and earnings growth remain positive at 13.1% and 10.2% YoY, but recent price performance is sharply negative (-22% over 1Y), and analyst target suggests upside to $211.30. The stock trades well above the Graham Number of $49.73, reflecting premium pricing for growth expectations despite mixed earnings surprise trends.